Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential

Bibliography

• Alarma-Estrany PP. J. Melatonin receptors in the eye: location, second messengers and role in ocular physiology. Pharmacol Ther 2007;113(3):507-22
   PubMed Web of Science ®Google Scholar
• Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Melatonin: nature's most versatile biological signal? FEBS J 2006;273(13):2813-38
   PubMed Web of Science ®Google Scholar
• Alarma-Estrany P, Crooke A, Pintor J. 5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit. J Pineal Res 2009;47(2):201-9
   PubMed Web of Science ®Google Scholar
• Dubocovich ML, Delagrange P, Krause DN, International union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 2010;62(3):343-80
   PubMed Web of Science ®Google Scholar
• Vincent L, Cohen W, Delagrange P, Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligand. J Pineal Res 2010;48(3):222-9
   PubMed Web of Science ®Google Scholar
• Anisimov SV, Popovic N. Genetic aspects of melatonin biology. Rev Neurosci 2004;15(3):209-30
   PubMed Web of Science ®Google Scholar
• Crooke A, Huete-Toral F, Martinez-Aguila A, Regulation of ocular adrenoceptor genes expression by 5-MCA-NAT: implications for glaucoma treatment. Pharmacogenet Genomics 2011;21(9):587-9
   PubMed Web of Science ®Google Scholar
• Crooke A, Huete-Toral F, Martinez-Aguila A, Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT. J Pineal Res 2011;52(3):265-70
   PubMed Web of Science ®Google Scholar
• Cardinali DP, Rosner JM. Metabolism of serotonin by the rat retina in vitro. J Neurochem 1971;18(9):1769-70
   PubMed Web of Science ®Google Scholar
• Cardinali DP, Rosner JM. Retinal localization of the hydroxyindole-O-methyl transferase (HIOMT) in the rat. Endocrinology 1971;89(1):301-3
   PubMed Web of Science ®Google Scholar
• Martin XD, Malina HZ, Brennan MC, The ciliary body–the third organ found to synthesize indoleamines in humans. Eur J Ophthalmol 1992;2(2):67-72
   PubMedGoogle Scholar
• Abe M, Itoh MT, Miyata M, Detection of melatonin, its precursors and related enzyme activities in rabbit lens. Exp Eye Res 1999;68(2):255-62
   PubMed Web of Science ®Google Scholar
• Rohde BH, McLaughlin MA, Chiou LY. Existence and role of endogenous ocular melatonin. J Ocul Pharmacol 1985;1(3):235-43
   PubMedGoogle Scholar
• DeMuro RL, Nafziger AN, Blask DE, The absolute bioavailability of oral melatonin. J Clin Pharmacol 2000;40(7):781-4
   PubMed Web of Science ®Google Scholar
• Gooneratne NS, Edwards AY, Zhou C, Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults. J Pineal Res 2012;52(4):437-45
   PubMed Web of Science ®Google Scholar
• Markantonis SL, Tsakalozou E, Paraskeva A, Melatonin pharmacokinetics in premenopausal and postmenopausal healthy female volunteers. J Clin Pharmacol 2008;48(2):240-5
   PubMed Web of Science ®Google Scholar
• Mistraletti G, Sabbatini G, Taverna M, Pharmacokinetics of orally administered melatonin in critically ill patients. J Pineal Res 2010;48(2):142-7
   PubMed Web of Science ®Google Scholar
• Yeleswaram K, McLaughlin LG, Knipe JO, Schabdach D. Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications. J Pineal Res 1997;22(1):45-51
   PubMed Web of Science ®Google Scholar
• Dubocovich ML. Pharmacology and function of melatonin receptors. FASEB J 1988;2(12):2765-73
   PubMed Web of Science ®Google Scholar
• Mor M, Rivara S, Pala D, Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists. Expert Opin Ther Pat 2010;20(8):1059-77
   PubMed Web of Science ®Google Scholar
• Gul M, Emre S, Esrefoglu M, Vard N. Protective effects of melatonin and aminoguanidine on the cornea in streptozotocin-induced diabetic rats. Cornea 2008;27(7):795-801
   PubMed Web of Science ®Google Scholar
• Anwar MM, Meki AR. Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin. Comp Biochem Physiol A Mol Integr Physiol 2003;135(4):539-47
   PubMed Web of Science ®Google Scholar
• Ciuffi M, Pisanello M, Pagliai G, Antioxidant protection in cultured corneal cells and whole corneas submitted to UV-B exposure. J Photochem Photobiol B 2003;71(1-3):59-68
   PubMed Web of Science ®Google Scholar
• Li ZR, Reiter RJ, Fujimori O, Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin. J Pineal Res 1997;22(3):117-23
   PubMed Web of Science ®Google Scholar
• Siu AW, Maldonado M, Sanchez-Hidalgo M, Protective effects of melatonin in experimental free radical-related ocular diseases. J Pineal Res 2006;40(2):101-9
   PubMed Web of Science ®Google Scholar
• Lundmark PO, Pandi-Perumal SR, Srinivasan V, Melatonin in the eye: implications for glaucoma. Exp Eye Res 2007;84(6):1021-30
   PubMed Web of Science ®Google Scholar
• Rosenstein RE, Pandi-Perumal SR, Srinivasan V, Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis. J Pineal Res 2010;49(1):1-13
   PubMed Web of Science ®Google Scholar
• Belforte NA, Moreno MC, de Zavalia N, Melatonin: a novel neuroprotectant for the treatment of glaucoma. J Pineal Res 2010;48(4):353-64
   PubMed Web of Science ®Google Scholar
• Siu AW, Reiter RJ, To CH. Pineal indoleamines and vitamin E reduce nitric oxide-induced lipid peroxidation in rat retinal homogenates. J Pineal Res 1999;27(2):122-8
   PubMed Web of Science ®Google Scholar
• Suzen S, Cihaner SS, Coban T. Synthesis and comparison of antioxidant properties of indole-based melatonin analogue indole amino Acid derivatives. Chem Biol Drug Des 2012;79(1):76-83
   PubMed Web of Science ®Google Scholar
• Mor M, Silva C, Vacondio F, Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities. J Pineal Res 2004;36(2):95-102
   PubMed Web of Science ®Google Scholar
• Camacho ME, Carrion MD, Lopez-Cara LC, Melatonin synthetic analogs as nitric oxide synthase inhibitors. Mini Rev Med Chem 2012;12(7):600-17
   PubMed Web of Science ®Google Scholar
• Kroger RH, Wagner HJ. The eye of the blue acara (Aequidens pulcher, Cichlidae) grows to compensate for defocus due to chromatic aberration. J Comp Physiol A 1996;179(6):837-42
   PubMed Web of Science ®Google Scholar
• Li T, Howland HC. The effects of constant and diurnal illumination of the pineal gland and the eyes on ocular growth in chicks. Invest Ophthalmol Vis Sci 2003;44(8):3692-7
   PubMed Web of Science ®Google Scholar
• Rada JA, Wiechmann AF. Melatonin receptors in chick ocular tissues: implications for a role of melatonin in ocular growth regulation. Invest Ophthalmol Vis Sci 2006;47(1):25-33
   PubMed Web of Science ®Google Scholar
• Schaeffel F, Bartmann M, Hagel G, Zrenner E. Studies on the role of the retinal dopamine/melatonin system in experimental refractive errors in chickens. Vision Res 1995;35(9):1247-64
   PubMed Web of Science ®Google Scholar
• Wang F, Zhou J, Lu Y, Chu R. Effects of 530 nm green light on refractive status, melatonin, MT1 receptor, and melanopsin in the guinea pig. Curr Eye Res 2011;36(2):103-11
   PubMed Web of Science ®Google Scholar
• Nickla DL, Wildsoet C, Wallman J. Visual influences on diurnal rhythms in ocular length and choroidal thickness in chick eyes. Exp Eye Res 1998;66(2):163-81
   PubMed Web of Science ®Google Scholar
• Papastergiou GI, Schmid GF, Riva CE, Ocular axial length and choroidal thickness in newly hatched chicks and one-year-old chickens fluctuate in a diurnal pattern that is influenced by visual experience and intraocular pressure changes. Exp Eye Res 1998;66(2):195-205
   PubMed Web of Science ®Google Scholar
• Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002;295(5557):1070-3
   PubMed Web of Science ®Google Scholar
• Crawford TN, Alfaro DV III, Kerrison JB, Jablon EP. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009;5(1):8-13
   PubMedGoogle Scholar
• do Carmo Buonfiglio D, Peliciari-Garcia RA, do Amaral FG, Early-stage retinal melatonin synthesis impairment in streptozotocin-induced diabetic wistar rats. Invest Ophthalmol Vis Sci 2011;52(10):7416-22
   PubMed Web of Science ®Google Scholar
• Hikichi T, Tateda N, Miura T. Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy. Clin Ophthalmol 2011;5:655-60
   PubMedGoogle Scholar
• Bardak Y, Ozerturk Y, Ozguner F, Effect of melatonin against oxidative stress in ultraviolet-B exposed rat lens. Curr Eye Res 2000;20(3):225-30
   PubMed Web of Science ®Google Scholar
• Karslioglu I, Ertekin MV, Taysi S, Radioprotective effects of melatonin on radiation-induced cataract. J Radiat Res (Tokyo) 2005;46(2):277-82
   PubMed Web of Science ®Google Scholar
• Taysi S, Memisogullari R, Koc M, Melatonin reduces oxidative stress in the rat lens due to radiation-induced oxidative injury. Int J Radiat Biol 2008;84(10):803-8
   PubMed Web of Science ®Google Scholar
• Yagci R, Aydin B, Erdurmus M, Use of melatonin to prevent selenite-induced cataract formation in rat eyes. Curr Eye Res 2006;31(10):845-50
   PubMed Web of Science ®Google Scholar
• Anwar MM, Moustafa MA. The effect of melatonin on eye lens of rats exposed to ultraviolet radiation. Comp Biochem Physiol C Toxicol Pharmacol 2001;129(1):57-63
   PubMed Web of Science ®Google Scholar
• Abe M, Reiter RJ, Orhii PB, Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. J Pineal Res 1994;17(2):94-100
   PubMed Web of Science ®Google Scholar
• Quigley HA. Glaucoma. Lancet 2011;377(9774):1367-77
   PubMed Web of Science ®Google Scholar
• Lee AJ, Goldberg I. Emerging drugs for ocular hypertension. Expert Opin Emerg Drugs 2011;16(1):137-61
   PubMed Web of Science ®Google Scholar
• Webers CA, Beckers HJ, Nuijts RM, Schouten JS. Pharmacological management of primary open-angle glaucoma: second-line options and beyond. Drugs Aging 2008;25(9):729-59
   PubMed Web of Science ®Google Scholar
• Grieshaber MC, Flammer J. Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance?–an exemplary analysis on the basis of two beta-blockers. Prog Retin Eye Res 2010;29(1):79-93
   PubMed Web of Science ®Google Scholar
• Carta F, Supuran CT, Scozzafava A. Novel therapies for glaucoma: a patent review 2007 - 2011. Expert Opin Ther Pat 2012;22(1):79-88
   PubMed Web of Science ®Google Scholar
• Do CW, Civan MM. Basis of chloride transport in ciliary epithelium. J Membr Biol 2004;200(1):1-13
   PubMed Web of Science ®Google Scholar
• Pattabiraman PP, Lih FB, Tomer KB, Rao PV. The role of calcium-independent phospholipase A2 gamma in modulation of aqueous humor drainage and Ca2+ sensitization of trabecular meshwork contraction. Am J Physiol Cell Physiol 2012;302(7):C979-91
   PubMed Web of Science ®Google Scholar
• Liu G, Zeng T, Yu W, Characterization of intraocular pressure responses of the Tibetan monkey (Macaca thibetana). Mol Vis 2011;17:1405-13
   PubMed Web of Science ®Google Scholar
• Liu H, Fan S, Gulati V, Aqueous humor dynamics during the day and night in healthy mature volunteers. Arch Ophthalmol 2011;129(3):269-75
   PubMed Web of Science ®Google Scholar
• Rowland JM, Potter DE, Reiter RJ. Circadian rhythm in intraocular pressure: a rabbit model. Curr Eye Res 1981;1(3):169-73
   PubMed Web of Science ®Google Scholar
• Zhao M, Hejkal JJ, Camras CB, Toris CB. Aqueous humor dynamics during the day and night in juvenile and adult rabbits. Invest Ophthalmol Vis Sci 2010;51(6):3145-51
   PubMed Web of Science ®Google Scholar
• Piccione G, Giannetto C, Fazio F, Giudice E. Influence of different artificial lighting regimes on intraocular pressure circadian profile in the dog (Canis familiaris). Exp Anim 2010;59(2):215-23
   PubMed Web of Science ®Google Scholar
• Pintor J, Martin L, Pelaez T, Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits. Eur J Pharmacol 2001;416(3):251-4
   PubMed Web of Science ®Google Scholar
• Pintor J, Pelaez T, Hoyle CH, Peral A. Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor. Br J Pharmacol 2003;138(5):831-6
   PubMed Web of Science ®Google Scholar
• Ismail SA, Mowafi HA. Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia. Anesth Analg 2009;108(4):1146-51
   PubMed Web of Science ®Google Scholar
• Samples JR, Krause G, Lewy AJ. Effect of melatonin on intraocular pressure. Curr Eye Res 1988;7(7):649-53
   PubMed Web of Science ®Google Scholar
• Osborne NN. Serotonin and melatonin in the iris/ciliary processes and their involvement in intraocular pressure. Acta Neurobiol Exp (Wars) 1994;54(Suppl):57-64
   PubMedGoogle Scholar
• Belforte N, Moreno MC, Cymeryng C, Effect of ocular hypertension on retinal nitridergic pathway activity. Invest Ophthalmol Vis Sci 2007;48(5):2127-33
   PubMed Web of Science ®Google Scholar
• Neufeld AH. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch Ophthalmol 1999;117(8):1050-6
   PubMed Web of Science ®Google Scholar
• Neufeld AH. Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma. Brain Res Bull 2004;62(6):455-9
   PubMed Web of Science ®Google Scholar
• Baltmr A, Duggan J, Nizari S, Neuroprotection in glaucoma - Is there a future role? Exp Eye Res 2010;91(5):554-66
   PubMed Web of Science ®Google Scholar
• Almasieh M, Wilson AM, Morquette B, The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res 2012;31(2):152-81
   PubMed Web of Science ®Google Scholar
• Sacca SC, Pascotto A, Camicione P, Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol 2005;123(4):458-63
   PubMed Web of Science ®Google Scholar
• Tezel G. The immune response in glaucoma: a perspective on the roles of oxidative stress. Exp Eye Res 2011;93(2):178-86
   PubMed Web of Science ®Google Scholar
• Agorastos A, Huber CG. The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential. J Pineal Res 2011;50(1):1-7
   PubMed Web of Science ®Google Scholar
• Morrison JC, Moore CG, Deppmeier LM, A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res 1997;64(1):85-96
   PubMed Web of Science ®Google Scholar
• Shareef SR, Garcia-Valenzuela E, Salierno A, Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res 1995;61(3):379-82
   PubMed Web of Science ®Google Scholar
• Sawada A, Neufeld AH. Confirmation of the rat model of chronic, moderately elevated intraocular pressure. Exp Eye Res 1999;69(5):525-31
   PubMed Web of Science ®Google Scholar
• Shareef S, Sawada A, Neufeld AH. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Invest ophthal vis sci 1999;40(12):2884-91
   PubMed Web of Science ®Google Scholar
• Benozzi J, Nahum LP, Campanelli JL, Rosenstein RE. Effect of hyaluronic acid on intraocular pressure in rats. Invest Ophthalmol Vis Sci 2002;43(7):2196-200
   PubMed Web of Science ®Google Scholar
• Moreno MC, Marcos HJ, Oscar Croxatto J, A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid. Exp Eye Res 2005;81(1):71-80
   PubMed Web of Science ®Google Scholar
• Moreno MC, Campanelli J, Sande P, Retinal oxidative stress induced by high intraocular pressure. Free Radic Biol Med 2004;37(6):803-12
   PubMed Web of Science ®Google Scholar
• Kilic E, Hermann DM, Isenmann S, Bahr M. Effects of pinealectomy and melatonin on the retrograde degeneration of retinal ganglion cells in a novel model of intraorbital optic nerve transection in mice. J Pineal Res 2002;32(2):106-11
   PubMed Web of Science ®Google Scholar
• Belforte N, Sande P, de Zavalia N, Effect of chondroitin sulfate on intraocular pressure in rats. Invest Ophthalmol Vis Sci 2010;51(11):5768-75
   PubMed Web of Science ®Google Scholar
• de Zavalia N, Plano SA, Fernandez DC, Effect of experimental glaucoma on the non-image forming visual system. J Neurochem 2011;117(5):904-14
   PubMed Web of Science ®Google Scholar
• Brainard GC, Hanifin JP, Greeson JM, Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 2001;21(16):6405-12
   PubMed Web of Science ®Google Scholar
• Serle JB, Wang RF, Peterson WM, Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes. J Glaucoma 2004;13(5):385-8
   PubMed Web of Science ®Google Scholar
• Nosjean O, Ferro M, Coge F, Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 2000;275(40):31311-17
   PubMed Web of Science ®Google Scholar
• Sampaio Lde F. An unexpected effect of 5-MCA-NAT in chick retinal development. Int J Dev neurosci 2009;27(6):511-15
   PubMed Web of Science ®Google Scholar
• Sampaio Lde F. Melatonin inhibitory effect on cAMP accumulation in the chick retina development. Int J Dev neurosci 2008;26(3-4):277-82
   PubMed Web of Science ®Google Scholar
• Alarma-Estrany P, Crooke A, Mediero A, Sympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbits. J Pineal Res 2008;45(4):468-75
   PubMed Web of Science ®Google Scholar
• Alarma-Estrany P, Guzman-Aranguez A, Huete F, Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits. J Pharmacol Exp Ther 2011;337(3):703-9
   PubMed Web of Science ®Google Scholar
• Pintor J, Martinez-Aguila A, Bergua A. Use of melatonin analogues for the reduction of the intraocular pressure. P201101173; 2011
   Google Scholar
• Gressens P, Schwendimann L, Husson I, Agomelatine, a melatonin receptor agonist with 5-HT(2C) receptor antagonist properties, protects the developing murine white matter against excitotoxicity. Eur J Pharmacol 2008;588(1):58-63
   PubMed Web of Science ®Google Scholar
• Del Sole MJ, Sande PH, Fernandez DC, Therapeutic benefit of melatonin in experimental feline uveitis. J Pineal Res 2012;52(1):29-37
   PubMed Web of Science ®Google Scholar
• Kukner A, Colakoglu N, Serin D, Effects of intraperitoneal vitamin E, melatonin and aprotinin on leptin expression in the guinea pig eye during experimental uveitis. Acta Ophthalmol Scand 2006;84(1):54-61
   PubMedGoogle Scholar
• Sande PH, Fernandez DC, Aldana Marcos HJ, Therapeutic effect of melatonin in experimental uveitis. Am J Pathol 2008;173(6):1702-13
   PubMed Web of Science ®Google Scholar
• Kaur C, Foulds WS, Ling EA. Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol 2008;2(4):879-89
   PubMedGoogle Scholar
• Kaur C, Sivakumar V, Yong Z, Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. J Pathol 2007;212(4):429-39
   PubMed Web of Science ®Google Scholar
• Kaur C, Sivakumar V, Foulds WS, Cellular and vascular changes in the retina of neonatal rats after an acute exposure to hypoxia. Invest Ophthalmol Vis Sci 2009;50(11):5364-74
   PubMed Web of Science ®Google Scholar
• Yilmaz T, Celebi S, Kukner AS. The protective effects of melatonin, vitamin E and octreotide on retinal edema during ischemia-reperfusion in the guinea pig retina. Eur J Ophthalmol 2002;12(6):443-9
   PubMed Web of Science ®Google Scholar
• Cai J, Nelson KC, Wu M, Oxidative damage and protection of the RPE. Prog Retin Eye Res 2000;19(2):205-21
   PubMed Web of Science ®Google Scholar
• Rosen R, Hu DN, Perez V, Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients. Mol Vis 2009;15:1673-9
   PubMed Web of Science ®Google Scholar
• Yi C, Pan X, Yan H, Effects of melatonin in age-related macular degeneration. Ann N Y Acad Sci 2005;1057:384-92
   PubMed Web of Science ®Google Scholar
• Rastmanesh R. Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity. Med Hypotheses 2011;76(1):79-85
   PubMed Web of Science ®Google Scholar
• Wiechmann AF, Chignell CF, Roberts JE. Influence of dietary melatonin on photoreceptor survival in the rat retina: an ocular toxicity study. Exp Eye Res 2008;86(2):241-50
   PubMed Web of Science ®Google Scholar
• Tomany SC, Cruickshanks KJ, Klein R, Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2004;122(5):750-7
   PubMed Web of Science ®Google Scholar
• Zhang R, Hrushesky WJ, Wood PA, Melatonin reprogrammes proteomic profile in light-exposed retina in vivo. Int J Biol Macromol 2010;47(2):255-60
   PubMed Web of Science ®Google Scholar
• Darzins P, Mitchell P, Heller RF. Sun exposure and age-related macular degeneration. An Australian case-control study. Ophthalmology 1997;104(5):770-6
   PubMed Web of Science ®Google Scholar
• Khan JC, Shahid H, Thurlby DA, Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight. Br J Ophthalmol 2006;90(1):29-32
   PubMed Web of Science ®Google Scholar
• Liang FQ, Aleman TS, Yang Z, Melatonin delays photoreceptor degeneration in the rds/rds mouse. Neuroreport 2001;12(5):1011-14
   PubMed Web of Science ®Google Scholar
• Lax P, Otalora BB, Esquiva G, Circadian dysfunction in P23H rhodopsin transgenic rats: effects of exogenous melatonin. J Pineal Res 2011;50(2):183-91
   PubMed Web of Science ®Google Scholar
• Hawlina M, Jenkins HG, Ikeda H. Diurnal variations in the electroretinographic c-wave and retinal melatonin content in rats with inherited retinal dystrophy. Doc Ophthalmol 1992;79(2):141-50
   PubMed Web of Science ®Google Scholar
• Iribarne M, Canto-Soler MV, Torbidoni V, Suburo AM. Controlling retinal pigment epithelium injury after experimental detachment of the retina. Invest Ophthalmol Vis Sci 2007;48(3):1348-54
   PubMed Web of Science ®Google Scholar
• Liang FQ, Green L, Wang C, Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress. Exp Eye Res 2004;78(6):1069-75
   PubMed Web of Science ®Google Scholar
• Osborne NN, Nash MS, Wood JP. Melatonin counteracts ischemia-induced apoptosis in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1998;39(12):2374-83
   PubMed Web of Science ®Google Scholar
• Er H, Turkoz Y, Mizrak B, Parlakpinar H. Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. Ophthalmologica 2006;220(1):17-22
   PubMed Web of Science ®Google Scholar